Overall, our current study revealed a novel regulatory mechanism on the interplay of invasive breast cancer cells and tumor infiltrating monocytes in the TME to promote breast cancer cell growth and metastasis, and CXCL7 may serve as a potential therapeutic target for breast cancer immunotherapy. Here, PPBP is linked to breast cancer.